Ken Griffin’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,330,035
| Closed | -$33.1M | – | 6684 |
|
2025
Q1 | $33.1M | Buy |
1,330,035
+1,282,548
| +2,701% | +$31.9M | 0.01% | 646 |
|
2024
Q4 | $895K | Sell |
47,487
-399,046
| -89% | -$7.52M | ﹤0.01% | 3376 |
|
2024
Q3 | $6.72M | Buy |
446,533
+146,471
| +49% | +$2.2M | ﹤0.01% | 1536 |
|
2024
Q2 | $8.58M | Buy |
300,062
+212,384
| +242% | +$6.08M | ﹤0.01% | 1303 |
|
2024
Q1 | $2.56M | Buy |
87,678
+79,145
| +928% | +$2.31M | ﹤0.01% | 2275 |
|
2023
Q4 | $288K | Sell |
8,533
-74,845
| -90% | -$2.53M | ﹤0.01% | 4277 |
|
2023
Q3 | $2.56M | Sell |
83,378
-726,772
| -90% | -$22.3M | ﹤0.01% | 2177 |
|
2023
Q2 | $32.5M | Buy |
810,150
+381,750
| +89% | +$15.3M | 0.01% | 590 |
|
2023
Q1 | $17.5M | Buy |
428,400
+141,034
| +49% | +$5.76M | ﹤0.01% | 924 |
|
2022
Q4 | $11.1M | Buy |
287,366
+265,825
| +1,234% | +$10.3M | ﹤0.01% | 1234 |
|
2022
Q3 | $1.15M | Buy |
+21,541
| New | +$1.15M | ﹤0.01% | 3277 |
|
2022
Q2 | – | Sell |
-107,884
| Closed | -$8.23M | – | 6682 |
|
2022
Q1 | $8.23M | Buy |
107,884
+3,094
| +3% | +$236K | ﹤0.01% | 1589 |
|
2021
Q4 | $6.31M | Buy |
104,790
+91,990
| +719% | +$5.53M | ﹤0.01% | 1894 |
|
2021
Q3 | $717K | Sell |
12,800
-65,514
| -84% | -$3.67M | ﹤0.01% | 4156 |
|
2021
Q2 | $4.75M | Buy |
78,314
+32,964
| +73% | +$2M | ﹤0.01% | 2213 |
|
2021
Q1 | $3.18M | Sell |
45,350
-63,114
| -58% | -$4.42M | ﹤0.01% | 2657 |
|
2020
Q4 | $6.49M | Sell |
108,464
-9,198
| -8% | -$550K | ﹤0.01% | 1552 |
|
2020
Q3 | $7.07M | Sell |
117,662
-50,441
| -30% | -$3.03M | ﹤0.01% | 1295 |
|
2020
Q2 | $8.82M | Buy |
168,103
+83,770
| +99% | +$4.4M | ﹤0.01% | 1166 |
|
2020
Q1 | $2.83M | Sell |
84,333
-219,113
| -72% | -$7.35M | ﹤0.01% | 1903 |
|
2019
Q4 | $13.7M | Buy |
303,446
+4,424
| +1% | +$200K | 0.01% | 1003 |
|
2019
Q3 | $11.4M | Sell |
299,022
-75,602
| -20% | -$2.88M | 0.01% | 1105 |
|
2019
Q2 | $16.3M | Buy |
374,624
+192,044
| +105% | +$8.35M | 0.01% | 911 |
|
2019
Q1 | $6.95M | Buy |
182,580
+13,341
| +8% | +$508K | ﹤0.01% | 1354 |
|
2018
Q4 | $7.28M | Sell |
169,239
-45,193
| -21% | -$1.94M | ﹤0.01% | 1193 |
|
2018
Q3 | $10.5M | Buy |
214,432
+179,795
| +519% | +$8.84M | ﹤0.01% | 1071 |
|
2018
Q2 | $1.11M | Buy |
34,637
+10,724
| +45% | +$344K | ﹤0.01% | 2577 |
|
2018
Q1 | $745K | Sell |
23,913
-214,654
| -90% | -$6.69M | ﹤0.01% | 2657 |
|
2017
Q4 | $10.9M | Buy |
238,567
+177,445
| +290% | +$8.1M | 0.01% | 911 |
|
2017
Q3 | $2.3M | Sell |
61,122
-26,633
| -30% | -$1M | ﹤0.01% | 1764 |
|
2017
Q2 | $4.19M | Sell |
87,755
-97,599
| -53% | -$4.66M | ﹤0.01% | 1283 |
|
2017
Q1 | $8.45M | Buy |
185,354
+108,424
| +141% | +$4.94M | 0.01% | 960 |
|
2016
Q4 | $2.49M | Sell |
76,930
-1,231,599
| -94% | -$39.8M | ﹤0.01% | 1394 |
|
2016
Q3 | $44.8M | Buy |
1,308,529
+771,927
| +144% | +$26.4M | 0.05% | 265 |
|
2016
Q2 | $18.1M | Buy |
+536,602
| New | +$18.1M | 0.02% | 511 |
|
2016
Q1 | – | Sell |
-126,397
| Closed | -$9.71M | – | 3786 |
|
2015
Q4 | $9.71M | Buy |
126,397
+35,326
| +39% | +$2.71M | 0.01% | 864 |
|
2015
Q3 | $3.74M | Buy |
91,071
+89,876
| +7,521% | +$3.69M | ﹤0.01% | 1375 |
|
2015
Q2 | $85K | Sell |
1,195
-32,383
| -96% | -$2.3M | ﹤0.01% | 3315 |
|
2015
Q1 | $2.98M | Buy |
+33,578
| New | +$2.98M | ﹤0.01% | 1544 |
|
2014
Q4 | – | Sell |
-17,748
| Closed | -$1.72M | – | 3948 |
|
2014
Q3 | $1.72M | Buy |
17,748
+6,969
| +65% | +$675K | ﹤0.01% | 1667 |
|
2014
Q2 | $990K | Sell |
10,779
-1,822
| -14% | -$167K | ﹤0.01% | 1854 |
|
2014
Q1 | $882K | Buy |
12,601
+12,573
| +44,904% | +$880K | ﹤0.01% | 1931 |
|
2013
Q4 | $2K | Sell |
28
-8,578
| -100% | -$613K | ﹤0.01% | 3049 |
|
2013
Q3 | $414K | Buy |
8,606
+6,234
| +263% | +$300K | ﹤0.01% | 1978 |
|
2013
Q2 | $69K | Buy |
+2,372
| New | +$69K | ﹤0.01% | 2494 |
|